Trial intelligence / Profile preview

Volulyte vs Voluven in Pediatric Cardiac Surgery

NCT02584868Phase 3Completed

Sponsor
Queen Fabiola Children's University Hospital
Start
Feb 2013
Primary completion
Nov 2016
Modality
Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hetastarch in hypovolemia, sponsored by Queen Fabiola Children's University Hospital. Started Feb 2013; status: completed.

02

Drugs

hetastarch
03

Conditions

hypovolemia

Beyond the preview

Go deeper on NCT02584868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02584868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call